Hemostasis Today

November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Devi G. Nair Enrolls First US Patient in Smartphone Camera Atrial Fibrillation Detection Study
Nov 20, 2026, 00:20

Devi G. Nair Enrolls First US Patient in Smartphone Camera Atrial Fibrillation Detection Study

Devi G Nair, Chief of Cardiac Electrophysiology and Research at St. Bernard’s Healthcare, shared Happitech’s post on LinkedIn:

“Proud of our team at St. Bernards Healthcare and the Arrhythmia Research Group for enrolling the first US patient in the Happitech smartphone PPG AF study.

In northeast Arkansas, AF too often announces itself as a stroke. If we can find it earlier, with a phone our patients already carry, we can change that story.

For communities far from a cardiologist, accessible screening could mean earlier diagnosis and earlier stroke prevention.

Proud to help generate the evidence.

Thank you to Happitech for partnering with a community program, and to our patients for helping move this question forward.”

Happitech shared a post on LinkedIn:

“Dr. Devi Nair and her team at St. Bernards have enrolled the first patient in Happitech’s US smartphone-based AF study.

In northeast Arkansas, too many of Dr. Devi G Nair patients first learn they have atrial fibrillation after a stroke.

Many live an hour or more from the nearest cardiologist. Nearly all of them carry a smartphone.

In her words:

‘A tool that could flag an irregular heart rhythm using the camera already in a patient’s pocket with no additional device to buy, wear or charge, could help us identify AF between clinic visits and get patients on stroke-preventing therapy sooner.’

The study, Detection of Atrial Fibrillation Using Photoplethysmography from Smartphone Cameras (NCT07779213), will test whether Happitech’s investigational Heart Rhythm Software can reliably meet that need.

Each participant has one extra, non-invasive PPG recording taken alongside their standard-of-care 12-lead ECG. Their clinical care stays the same.

Four sites in the United States and one in the Netherlands are enrolling patients.

The data are intended to support a future FDA 510(k) submission.

Thank you to Dr. Nair and the team at St. Bernards Healthcare and the Arrhythmia Research Group for enrolling the first patient and getting the study under way.

Dr. Devi Nair is Chief of Cardiac Electrophysiology and Research at St. Bernards Healthcare and CEO of the Arrhythmia Research Group, Jonesboro, Arkansas.

Caution: Investigational device. Limited by United States law to investigational use.

Not cleared or approved by the US FDA.”

Stay updated with Hemostasis Today.